News summary
[Health Yuan: Obtained the drug registration certificate of fluticasone propionate suspension for aerosol inhalation] Securities Times e Company Newsandroidgameblockchain, Health Yuan (600380) announced on the evening of May 27 that its holding subsidiary Shanghai Fangyu received approval and issuance from the State Drug AdministrationandroidgameblockchainFluticasone propionate suspension for aerosol inhalationandroidgameblockchain.androidgameblockchain..
Newsletter text
[Health Yuan: Obtained the drug registration certificate of fluticasone propionate aerosol suspension for inhalation] Securities Times e Company News, Health Yuan (600380) announced on the evening of May 27 that its holding subsidiary Shanghai Fangyu received the "Drug Registration Certificate" of fluticasone propionate aerosol suspension for inhalation approved and issued by the Administration. This product is suitable for the treatment of mild to moderate acute asthma attacks in children and adolescents aged 4 - 16.
